Chargement en cours...
Advances in sarcoma genomics and new therapeutic targets
Increasingly, human mesenchymal malignancies are classified by the abnormalities that drive their pathogenesis. While many of these aberrations are highly prevalent within particular sarcoma subtypes, few are currently targeted therapeutically. Indeed, most subtypes of sarcoma are still treated with...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361898/ https://ncbi.nlm.nih.gov/pubmed/21753790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc3087 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|